Author

Bilal A. Omar

AstraZeneca (United States)ORCID 0000-0001-7332-8312Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:mechanistic / dynamical model· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Ali MostafaiD· 1 shared Ana Maria MansillaiD· 1 shared Ana PaucarmaytaiD· 1 shared Anna HuntleyiD· 1 shared Carolina Mendoza-Topaz· 1 shared Christine Mione KieferiD· 1 shared Christine YouniD· 1 shared Corinne CayatteiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Ali MostafaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologybioRxivPreprintJul 22, 2026

Mechanisms regulating combination effect of antibody-drug conjugates and cancer immunotherapy

Şehmus Tohumeken, Ali Mostafa, Rashmi Binjawadagi…·Dmitry I. Gabrilovich

This paper investigates the mechanisms of ADC-immunotherapy combinations, finding that ADC-induced autophagy upregulates TNFR and M6PR, driving antitumor effects through TNF and granzyme B pathways.

DOI 10.64898/2026.07.17.738956

humanproteomics

𝕏 PostBluesky